FilingSEC EDGAR8-K
Tempest Therapeutics Adjourns Special Meeting to October 14
· SEC accepted
StageAdjourned
Filing content
The company adjourned its special meeting to October 14 due to a lack of sufficient votes to approve the proposed charter amendment.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…